Document Detail


Benzo[a]pyrene-7,8-dihydrodiol promotes checkpoint activation and G2/M arrest in human bronchoalveolar carcinoma H358 cells.
MedLine Citation:
PMID:  17114299     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Polycyclic aromatic hydrocarbons (PAHs) are potent carcinogens that require metabolic activation inside cells. The proximate carcinogens PAH-diols can be converted to o-quinones by aldo-keto reductases (AKRs) or to diol-epoxides by cytochrome P450 (P450) enzymes. We assessed the effect of benzo[a]pyrene-7,8-dihydrodiol (BPD) on proliferation in p53-null bronchoalveolar carcinoma H358 cells. BPD treatment led to a significant inhibition of proliferation and arrest in G2/M in H358 cells. The relative contribution of the AKR and P450 pathways to cell cycle arrest was assessed. Overexpression of AKR1A1 did not affect cell proliferation or cell cycle progression, and benzo[a]pyrene-7,8-dione did not cause any noticeable effect on cell growth, suggesting that AKR1A1 metabolic products were not involved in the antiproliferative effect of BPD. On the other hand, blockade of P450 induction or inhibition of P450 activity greatly impaired the effect of BPD. Moreover, P450 induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin significantly enhanced the antiproliferative effect of BPD. Mechanistic studies revealed that BPD caused a DNA damage response, Chk1 activation, and accumulation of phospho-Cdc2 (Tyr15) in H358 cells, effects that were impaired by an ataxia-telangectasia mutated (ATM)/ATM-related (ATR) inhibitor. Similar results were observed in human bronchoepithelial BEAS-2B cells, arguing for analogous mechanisms in tumorigenic and immortalized nontumorigenic cells lacking functional p53. Our data suggest that a p53-independent pathway operates in lung epithelial cells in response to BPD that involves P450 induction and subsequent activation of the ATR/ATM/Chk1 damage check-point pathway and cell cycle arrest in G2/M.
Authors:
M Cecilia Caino; Jose L Oliva; Hao Jiang; Trevor M Penning; Marcelo G Kazanietz
Related Documents :
8021299 - Both viral (adenovirus e1b) and cellular (hsp 70, p53) components interact with centros...
11225849 - Biological and molecular characterization of an ecv-304-derived cell line resistant to ...
9247309 - Heat shock induces transient p53-dependent cell cycle arrest at g1/s.
12432259 - Flavopiridol inversely affects p21(waf1/cip1) and p53 and protects p21-sensitive cells ...
11431359 - Role of the hmlh1 dna mismatch repair protein in fluoropyrimidine-mediated cell death a...
11095619 - Induction of cell cycle entry and cell death in postmitotic lens fiber cells by overexp...
3541659 - Normal distribution of lysozyme- and lactoferrin-secreting cells in the chinchilla tubo...
9862839 - Inhibitory effect of oestradiol on activation of rat hepatic stellate cells in vivo and...
2093009 - Role of gastrin as a trophic hormone.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2006-11-17
Journal Detail:
Title:  Molecular pharmacology     Volume:  71     ISSN:  0026-895X     ISO Abbreviation:  Mol. Pharmacol.     Publication Date:  2007 Mar 
Date Detail:
Created Date:  2007-02-19     Completed Date:  2007-03-22     Revised Date:  2011-11-02    
Medline Journal Info:
Nlm Unique ID:  0035623     Medline TA:  Mol Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  744-50     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6160, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma, Bronchiolo-Alveolar / pathology*
Cell Division / drug effects*
Cell Line, Tumor
Cell Proliferation / drug effects
Cytochrome P-450 Enzyme System / physiology
DNA Damage
Dihydroxydihydrobenzopyrenes / metabolism,  pharmacology*
Enzyme Activation
G2 Phase / drug effects*
Humans
Lung Neoplasms / pathology*
Protein Kinases / physiology*
Grant Support
ID/Acronym/Agency:
P01-DA92573/DA/NIDA NIH HHS; P30-ES013508/ES/NIEHS NIH HHS
Chemical
Reg. No./Substance:
0/Dihydroxydihydrobenzopyrenes; 13345-25-0/benzo(a)pyrene 7,8-dihydrodiol; 9035-51-2/Cytochrome P-450 Enzyme System; EC 2.7.-/Protein Kinases; EC 2.7.11.1/Checkpoint kinase 1

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Protease-activated receptor-2 protects against pancreatitis by stimulating exocrine secretion.
Next Document:  Satisfaction with present life predicts survival in octogenarians.